Editorial
|
|
|
|
|
Amidst pressure from media, advertising and government, time to stop and ask some basic questions
|
|
|
|
Marketing Authorisations
|
|
|
|
|
A long-acting beta-2 agonist, no advantages in COPD
|
|
|
|
|
|
|
|
|
|
Herpes labialis: a topical antiviral drug perhaps, but not a steroid
|
|
|
|
|
|
|
|
|
|
|
|
Now authorised for children, but no suitable form
|
|
|
|
|
|
|
|
|
|
|
|
Reviews
|
|
|
|
|
Always limit the dose and duration of treatment with NSAIDs
|
|
|
|
|
|
Outlook
|
|
|
|
|
Should be part of medical training
|
|
|
|
|
|
|
|
|
|
Changing the world but not alone
|
|
|
|
|
|
|
|